Log In
Register
Facebook icon
LinkedIn icon
Instagram icon
Cosmetic Ingredients
Formulas/Products
Research
Regulations
Testing
News
Leaders
Multimedia
Calendar
Home
Search
Search Cosmetics & Toiletries
Article
Company
Document
Event
News
Podcast
Video
Webcast
Cosmetic Ingredients
Actives
Balancing/Soothing
Cleansing
Colorant
Conditioning
Formulating Aids
Moisturizing
Natural/Sustainable
Oral Care
Preservation
Rheology/Thickener
Sensory
Specialized
Tech/Equipment
Formulas/Products
Multimedia
News
Regulations
Research
Testing
Enter search phrase
Search
180 Results
Section: Cosmetic Ingredients
SPF/Sun
DSM Seeks FDA Sunscreen Monograph Approval of Bemotrizinol
DSM believes it is important for consumers in the USA to benefit from the efficacy and aesthetics that modern filters such as BEMT can provide. As such, the company is pushing for Monograph status.
Literature/Data
Literature Review Connects Sunscreen Absorption with Potential Adverse Effects
A literature review published in
Dermatology Research
suggests the potential adverse effects, i.e., irritation, rashes, hormone disruption, etc., of sunscreen ingredients absorbed into human skin and present in human plasma and urine.
Sun Care
Industry Debate: US FDA vs. Sunscreens
During last month’s NYSCC Suppliers' Day, several attendees expressed frustration regarding the delay of the US Food and Drug Administration’s Final Sunscreen Monograph.
Cosmetics & Toiletries
asked its
LinkedIn
members to comment. Here’s what the market had to say.
SPF/Sun
FDA Reviews Sunscreen Active
The Food and Drug Administration(FDA) has requested safety and efficacy data for the sunscreen active ingredient diethylhexyl butamido triazone in concentrations...
SPF/Sun
[podcast] Why the FDA Disallows Europe’s Sunscreens
Between limited UV filter options and bans on organic sunscreens, the U.S. sunscreen market is wrought with strife. So why not just add Europe's UV filters to expand the U.S. portfolio? As David Steinberg explains in this podcast, it's not that easy. Listen now.
Safety/Stability
Why the FDA's 'Sunscreens in the Bloodstream' Study is Flawed
A recent study published in the
Journal of the American Medical Association
tested the potential systemic absorption of certain sunscreens. Results identified their presence in subjects' bloodstreams; however, as industry expert David Steinberg explains, the study is misleading and fails to consider crucial variables.
Regional
Could the FDA Sunscreen Monograph See a New Addition?
It's been decades since the FDA's OTC Sunscreen Monograph welcomed a new addition; back then, it was avobenzone. Now, another could be joining the ranks.
SPF/Sun
Sunscreen Innovation Act Introduced into Congress to Amend FDA's TEA Program
On Mar. 13, 2014, U.S. Senator Jack Reed (D-RI) and U.S. Congressman Ed Whitfield (R-KY) introduced the bipartisan, bicameral Sunscreen Innovation Act (S. 2141 and H.R. 4250, respectively), which has been supported by the Public Access to SunScreen (PASS) Coalition.
SPF/Sun
FDA Publishes Opinion on Two Sunscreen TEAs and Is Urged for More Action by PASS
The end of February was busy for the U.S. Food and Drug Administration (FDA), which published two letters on the Time and Extent Applications (TEAs) for diethylhexyl butamido triazone (Uvasorb HEB) and amiloxate (Neo Heliopan E 1000), finding insufficient scientific evidence to claim either as generally recognized as safe and effective (GRASE) and denying their addition to the OTC Sunscreen Monograph.
Regional
Sunscreen Innovation Act Passes: What Does it Mean?
The Public Access to SunScreens (PASS) Coalition applauded the U.S. Senate's passage of the Sunscreen Innovation Act (S. 2141). While the Act aims to streamline the approval process for new sunscreen actives, will it? Industry expert David Steinberg gives his take.
Claims/Labeling
FDA Weighs in on Holographic Cosmetics
Holographic, iridescent and other special effect color additives have been allowed to shine in recent consumer trends. Click through for the U.S. Food and Drug Administration's take on how these additives are regulated.
Claims/Labeling
FDA Issues New Guidances on Nanotechnology
The US Food and Drug Administration has issued two new draft guidances on the use of nanotechnology by the cosmetics and foods industries.
Actives
U.S. FDA Hand Sanitizer Solutions Explained
The U.S. Food and Drug Administration has liberalized the compounding of alcohol-based hand sanitizers such that any registered compounder can create these products as long as they follow the published formulas and guidelines. This article clears up the math on what these guidelines allow.
Regional
FDA and SDA Address Triclosan Concern
The FDA updated its Web site on Apr. 8, 2010, with its most recent information on triclosan. According to the FDA, triclosan provides a benefit to a number of personal care products, and it does not have sufficient safety evidence to recommend changing consumer use of products that contain triclosan. However, the FDA also did not have evidence that triclosan provided any additional benefit when added to antibacterial soaps and body washes.
Claims/Labeling
FDA to Focus on Nanotech Trend
The FDA announced plans to focus on nanotechnology at a public meeting to be held later this year...
Colorant
New Black Pigment Approved By FDA
D&C Black No. 3, or "bone black," has been approved by the US Food and Drug Administration (FDA) for formulation into eye shadow, eyeliner, mascara and face powder.
Regional
FDA Petitioned to Assess Nanotech Risk
CTA and a coalition of consumer, health and environmental groups called on the FDA to address nanomaterials in consumer products.
Claims/Labeling
FDA Issues Final Guidance on Nanomaterials
On June 26, 2014, The U.S. Food and Drug Administration (FDA) issued Final Guidance for Industry: Safety of Nanomaterials in Cosmetics, a final guidance document addressing the use of nanotechnology in cosmetics.
Page 1 of 10
Next Page